AV Access Study to be Presented at the Vascular Annual Meeting (VAM25)DURHAM, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company ...

Positive new data suggests that more people facing advanced breast cancer may be able to put off treatment with harsh ...